Professionals and Partners
Go to Professionals and Partners

Professionals and Partners

Our core expertise is the development and manufacturing of high-quality generic and in-licensed medicines with a proven cost-effectiveness ratio.

Individuals and Families
Go to Individuals and Families

Individuals and Families

We believe in improving the life of individuals and families by using the best current research. We use our resources to drive future scientific and manufacturing development for the constant betterment of therapies.

Home

Tchaikapharma High Quality Medicines Inc. is devoted to providing individuals and families with a wide range of affordable contemporary high-quality pharmaceuticals fighting socially significant diseases.

  • April 4, 2022

    The pandemic has caused problems in the forefront of predictability and access to medicines in the country. It was difficult to supply the basic (active) substances for pharmaceutical production, and a slight increase in the production of drugs.   In this context, even before the first global lockdown, the team of Tchaikapharma has prepared a […]

  • April 1, 2022

    The first humanitarian aid from Pleven is already on its way to the twin city of Nikolayev, expected to arrive tomorrow at noon. The main donation consists of antiviral preparations, sleeping bags, external batteries for charging mobile phones, backpacks, lanterns – these were the requests of the local government in Nikolaev. The medicines were provided […]

  • March 15, 2022

    2021 was a very successful year for the manufacturing facilities of Tchaikapharma High Quality Medicines in Plovdiv and Varna. Numerous improvements related to the modernization of the manufactiring process were introduced at the company’s plant in Plovdiv: – a Production Permit was obtained for a new granulation room in the tablet manufacturing facility, doubling the […]

  • February 7, 2022

    The Company reports about growth in sales of antibiotics and respiratory drugs   Tchaikapharma High Quality Medicines Inc. reports revenue growth and profit more than doubling by the end of 2021.  The company’s net profit at the end of the last quarter for 2021 amounted to BGN 1,667 million compared to BGN 604 thousand at […]

  • January 10, 2022

    The newest medicinal product to receive a Marketing Authorization from the Bulgarian Drug Agency is:   TromBay 100 mg tablets (with active ingredient cilostazol).   Its actions are several and include dilating certain blood vessels and reducing the clotting activity (agglutination) of certain blood cells, called platelets, in blood vessels.   The medicinal product is […]